Myelodysplastic Syndrome:A Clinical Study of 99 Cases.

DING Kai-yang,JI Wen-can,ZHU Wei-bo,WU Jing-sheng,CAI Xiao-yan,LIU Xin,YANG Hui-zhi,ZHENG Chang-cheng
2011-01-01
Abstract:Objective To study the WHO classification and cytogenetic characteristics in patients with myelodysplastic syndrome(MDS),and to explore their relationship with diagnosis,progression and prognosis of MDS.Methods Ninty-nine adult patients with primary MDS,admitted to Anhui Provincial Hospital of Anhui Medical University between January 2001 and December 2007,were enrolled in the study.We retrospectively analyzed their chromosomal karyotypes,WHO classifications and prognosis.A follow-up study and correlation analysis were performed.Results Among the 99 MDS cases,26(26.26%) were diagnosed with RA,6(6.06%) with RAS,23(23.23%) RCMD and 44(44.44%) RAEB.According to IPSS chromosomal prognostic classification,the detection rate of abnormal karyotype was significantly higher in int-Ⅱ/high risk groups than that in low/int-Ⅰ risk groups(χ2=17.88,P0.01);the incidence of acute leukemia(AL) was significantly higher in int-Ⅱ/high risk groups than that in low/int-Ⅰ risk groups(χ2=40.22,P0.01).According to IPSS chromosomal karyotype classification,the median survival time of patients with good,moderate and poor prognosis were 45(95%CI:39~51),37(95%CI:25~49) and 23(95%CI:13~31) months respectively,with a statistical significance found in overall survival(OS) rates of these three groups(P=0.010).Conclusion The features of WHO classification in Chinese patients with primary MDS are different from those in Western countries,and the chromosome karyotype may be of great importance for diagnostic classification and prognostic evaluation of MDS.
What problem does this paper attempt to address?